高级检索
赵美英, 柯小俊. 希递康对免疫低下人群T淋巴细胞亚群提升作用[J]. 中国公共卫生, 2001, 17(2): 120-121. DOI: 10.11847/zgggws2001-17-02-18
引用本文: 赵美英, 柯小俊. 希递康对免疫低下人群T淋巴细胞亚群提升作用[J]. 中国公共卫生, 2001, 17(2): 120-121. DOI: 10.11847/zgggws2001-17-02-18
ZHAO Mei-ying, . CD Health Capsule's Improve Effect on the T Lymphocyte Subgroups of Low Immunity Population[J]. Chinese Journal of Public Health, 2001, 17(2): 120-121. DOI: 10.11847/zgggws2001-17-02-18
Citation: ZHAO Mei-ying, . CD Health Capsule's Improve Effect on the T Lymphocyte Subgroups of Low Immunity Population[J]. Chinese Journal of Public Health, 2001, 17(2): 120-121. DOI: 10.11847/zgggws2001-17-02-18

希递康对免疫低下人群T淋巴细胞亚群提升作用

CD Health Capsule's Improve Effect on the T Lymphocyte Subgroups of Low Immunity Population

  • 摘要: 目的观察希递康(CDH)胶囊对免疫低下人群T淋巴细胞提升效果.方法通过严格现场质量控制,对淋巴细胞<1200/μl的自愿服用者,经过1个疗程,T淋巴细胞采用流式细胞仪测定.结果CDH对免疫低下者的淋巴细胞,CD3+及CD4+数的提升效果极为显着(P<0.01),平均接近50%.增加CD4+>40个/μl有82.5%,其中增加CD4+>200个/μl有7例,CD4+增加和CD4+/CD8+增加>0.2有6例,显效率占32.5%.结论CDH具有提升CD4+细胞作用,激发免疫应答功能,增强对传染病的抵抗力.

     

    Abstract: ObjectiveTo observe the CD health(CDH,SeLEN)capsule's improve effect to low immunity population.T lymphocyte subg roup.By strictfield quantity control,the observation object,the volunteers with LYM<1200/μl,after one course of treatment,measuring the T lymphocyte by flow cytometer.The results showed that the effect that CDH improve lowimmunity people's lymphocyte,CD3+ and CD4+ was very obvious(P<0.01),average closed to 50%.There was 82.5% increased CD4+ >40/μl,and 7 cases.CD4+>200/Ll,and 6 cases increased both CD4+ and CD4+/CD8+(>0.2),the effect rate was 32.5%.This prove that CDH has improve effect on CD4+,stimulates immunity response function and streng thens the resistibility against pandmic.

     

/

返回文章
返回